2024-02-03 05:17:20 ET
Summary
- Danaher's annual results show a decrease in sales and EBIT due to the boost in sales of the COVID-19 pandemic.
- The company has made strategic acquisitions and spin-offs to improve its business segments and position itself for long-term growth.
- Danaher's participation in the J.P. Morgan Annual Healthcare Conference highlighted its recurring demand, potential growth opportunities, and focus on attractive end markets.
...
Read the full article on Seeking Alpha
For further details see:
Danaher: Better Positioned For The Future